Viking Therapeutics Inc
Biotechnology
Healthcare
VKTX
111 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
27.11
52 week high
78.03
high
27.39
52 week low
19.98
low
25.78
growth
-59.40 %
previous Close
26.95
P/E ratio
market cap
4.72 B
div yield
0
net incoming
-24.94 M
-12.09 %
net profit margin
-2494000000.00 %
0.00 %
operating incoming
-36.56 M
-7.35 %
net change in cash
6.43 M
104.24 %
cash on hand
50.35 M
14.65 %
cost of revenue
87.00 K
16.00 %
top